Brookline Capital Acquisition Corp WT (BCACW)
Brookline Capital Acquisition Corp WT (BCACW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCACW | SCNI | CUVL | ||
| Company | Brookline Capital Acquisition Corp WT | Scinai Immunotherapeutics Ltd ADR | Clinuvel Pharmaceuticals Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.2450 | 2.42 | 6.25 | ||
| High | 0.6799 | 2.43 | 6.35 | ||
| Low | 0.2450 | 2.26 | 6.25 | ||
| Last | 0.5500 | 2.34 | 6.30 | ||
| Change | +0.3100 | -0.12 | +0.06 | ||
| Percent Change | +129.17% | -4.88% | +0.96% | ||
| Volume | 901,100 | 27,073 | 20,604 | ||
| 20-Day Average Volume | 59,175 | 77,594 | 14,555 | ||
| Previous | 0.2400 | 2.46 | 6.24 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1819 | 2.60 | 6.83 | ||
| 20-Day Raw Stochastic | 77.37% | 7.56% | 15.56% | ||
| 20-Day Relative Strength | 84.53 | 40.35 | 43.51 | ||
| Weighted Alpha | -69.67 | -85.96 | -17.95 | ||
| Today's Opinion | 8% Buy | 80% Sell | 88% Sell | ||
| Yesterday's Opinion | 24% Sell | 72% Sell | 72% Sell | ||
| Last Month's Opinion | 96% Sell | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +185.42% since 07/22/22 | -21.25% since 08/26/26 | -17.58% since 08/26/26 | ||
| Low | 0.1500 on 07/25/22 | 2.26 on 09/02/26 | 5.95 on 08/31/26 | ||
| High | 0.6799 on 07/29/22 | 2.98 on 08/28/26 | 7.96 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | +358.33% since 06/28/22 | -17.22% since 07/31/26 | -2.93% since 07/31/26 | ||
| Low | 0.1002 on 06/30/22 | 2.15 on 08/06/26 | 5.95 on 08/31/26 | ||
| High | 0.6799 on 07/29/22 | 3.80 on 08/03/26 | 8.20 on 08/24/26 | ||
| 3-Month | |||||
| %Chg | +292.86% since 04/29/22 | -52.82% since 06/02/26 | -2.78% since 06/02/26 | ||
| Low | 0.0600 on 05/12/22 | 2.15 on 07/15/26 | 5.95 on 08/31/26 | ||
| High | 0.6799 on 07/29/22 | 4.75 on 06/03/26 | 8.20 on 08/24/26 | ||
| 6-Month | |||||
| %Chg | +52.78% since 01/28/22 | -73.41% since 03/02/26 | -15.04% since 03/02/26 | ||
| Low | 0.0600 on 05/12/22 | 2.15 on 07/15/26 | 5.95 on 08/31/26 | ||
| High | 0.6799 on 07/29/22 | 10.50 on 04/24/26 | 8.20 on 08/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | 1,272 | 0 | ||
| Shares Outstanding, K | N/A | 517 | 0 | ||
| Annual Sales, $M | 0 | 1,310,000 | 94,024,398 | ||
| Annual Net Income, $M | -480,000 | -8,310,000 | 33,916,819 | ||
| Last Qtr Sales, $M | 0 | 460,000 | N/A | ||
| Last Qtr Income, $M | -2,457,658 | -2,000,000 | N/A | ||
| 60-Month Beta | N/A | 2.08 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.74 on 08/24/26 | N/A | ||
| Latest Earnings Date | 01/01/70 | 11/23/26 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | 09/08/26 | ||
| Ratios | |||||
| Price/Earnings ttm | N/A | 0.00 | 0.00 | ||